A 2002 study published in the International Journal of Cosmetic Science reviews the effects of healthy women using a topical cream containing 10% Argireline (hexapeptide-3)
8-week on, 4-week off example: Weeks 1-2: Assessment and dose finding (every other day) Weeks 3-6: Optimization phase (3-5 times weekly) Weeks 7-8: Maintenance (3 times weekly) Weeks 9-12: Complete break, no DSIP During the off period, focus on sleep hygiene fundamentals: consistent wake times, light exposure management, temperature optimization, and stress reduction
Optimal dosing for neuropathy applications is extrapolated from general tissue repair protocols rather than neuropathy-specific dose-finding studies for most peptides
Impairment of the intestinal barrier is evident in untreated but absent in suppressively treated HIV-infected patients
These side effects were usually mild or moderate, often improved with time, and only a small number of participants stopped treatment because of them